Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old

Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old

The purpose of this study is to determine the safety, efficacy, predictability, and stability of laser in situ keratomileusis (LASIK) to correct high anisometropia in patients 8 to 15 years old in whom conventional treatments have failed.

Nine eyes of nine patients (3 male and 6 female) with high anisometropia (>3.50 D), were included in this study. Minimum follow-up was 10 years. All patients were treated with the Chiron Technolas 217 excimer laser.

Inclusion Criteria:

• High anisometropia (>3.50 D)
• Patients 8 to 15 years old
• Conventional treatments have failed

Exclusion Criteria:

• Diabetes
• Autoimmune diseases
• Topographic abnormalities